Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy and Stereotactic Radiation Therapy or Immunotherapy Alone: A National Cancer Database Analysis.

Adv Radiat Oncol · 2023 · PMC10318269 · PMID 37408680

Europe PMC DOI

hedged sentence

0.1077

closest p · 2.2× alpha

0.1077

boldest claim

The sentences

did not reach statistical significanceP = .1077not close (p > 0.1)

OS was 74.4% versus 65.0% at 1 year and 71.0% versus 59.4% at 2 years for the IO + SRT and IO alone groups, respectively, although this difference did not reach statistical significance (log-rank P = .1077).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.